Page last updated: 2024-10-22

tyrphostin a23 and Kidney Neoplasms

tyrphostin a23 has been researched along with Kidney Neoplasms in 1 studies

tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laping, NJ1
Olson, BA1
DeWolf, RE1
Albrightson, CR1
Fredrickson, T1
King, C1
Chirivella, M1
Ziyadeh, FN1
Nambi, P1

Other Studies

1 other study available for tyrphostin a23 and Kidney Neoplasms

ArticleYear
Activation of glomerular mesangial cells by hepatocyte growth factor through tyrosine kinase and protein kinase C.
    Biochemical pharmacology, 1998, Jan-15, Volume: 55, Issue:2

    Topics: Androstadienes; Animals; Catechols; Cells, Cultured; Cryopreservation; Enzyme Inhibitors; Epidermal

1998